Malignant plural mesothelioma2 Feb 2019
Anna Bibby joins The Lancet Oncology to discuss recent developments in the treament of malignant plural mesothelioma.
CAR T-cell therapy3 Jan 2019
Frederick Locke joins The Lancet Oncology to discuss long-term results from the ZUMA-1 trial on the safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma.
Cervical cancer screening in older women29 Nov 2018
Talía Malagón discusses her modelling study which assesses the age at which to stop cervical cancer screening in older women and the remaining lifetime risk of cervical cancer.
Palliative care in oncology18 Oct 2018
Stein Kaasa and Jon Loge discuss their new Commission on palliative care.
Global review of cancer control27 Sep 2018
Andre Ilbawi talks about his global analysis of available national cancer control plans with The Lancet Oncology.
Are patient reported outcomes consistent?31 Aug 2018
A review in The Lancet Oncology asks whether patient reported outcomes in RCTs are consistent across their analysis, reporting, and interpretation. Author Madeline Pe discusses the findings.
Changing incidence of adolescent cancer31 Aug 2018
Eva Steliarova-Foucher joins The Lancet Oncology to discuss the Europe-wide Automated Childhood Cancer Information System, and the increase in cancer incidence rates among children and adolescents.
Diffuse intrinsic pontine glioma14 Aug 2018
Mark Souweidane joins The Lancet Oncology to discuss his dose-escalation study, assessing a convection-enhanced delivery for diffuse intrinsic pontine glioma.
Bo Jan Noordman joins The Lancet Oncology to discuss the findings from his study of residual disease detection in oesophageal cancer.
Gender and cancer immunotherapy efficacy1 Jun 2018
Fabio Conforti talks to The Lancet Oncology about a meta-analysis showing that a patient's sex can affect the efficacy of cancer immunotherapy.
PROs in regulatory decision making25 Apr 2018
Paul Kluetz from the US FDA discusses the issues surrounding the use of patient-reported outcomes in regulatory decision making.
Vulvar field resection29 Mar 2018
Michael Hoeckel joins The Lancet Oncology to discuss his latest trial on the surgical treatment of vulvar carcinoma based on the theory of ontogenetic cancer fields.
Håvard Emil Danielsen joins The Lancet Oncology to discuss his latest paper on machine learning algorithms to analyse chromatin organisation as a prognostic marker for cancer.
Ross Camidge discusses RANO's papers on clinical trial design for patients with brain metastases.
John Field discusses a European position statement on lung cancer screening using low-dose CT.
Commission co-chairs Chi Van Dang and Elizabeth M. Jaffee discuss a new Lancet Oncology Commission on cancer treatment and care in the USA.
Cancer in Peru: The Lancet Oncology28 Sep 2017
Ben Anderson talks about cancer care and cancer trends in Peru.
Ricky Sharma discusses results from three prospective trials on the use of selective internal radiotherapy for liver metastases from colorectal cancer.
Samra Turajlic discusses the contribution of small insertions and deletions to tumour-specific antigen analyses.
Percy Lee discusses the impact of prior radiotherapy on the efficacy of pembrolizumab when used to treat non-small cell lung cancer.
© 2009 - 2018 Ebling Library, UW-Madison
750 Highland Ave, Madison, WI, 53705-2221